Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Oct;55(10):870–877. doi: 10.1136/thorax.55.10.870

Churg-Strauss syndrome

M Conron 1, H Beynon 1
PMCID: PMC1745623  PMID: 10992542

Full Text

The Full Text of this article is available as a PDF (202.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi J. D., Bensen W. G., Bianchi F., Cividino A., Pillersdorf S., Sebaldt R. J., Tugwell P., Gordon M., Steele M., Webber C. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol. 1996 Jun;23(6):995–1000. [PubMed] [Google Scholar]
  2. Adachi J., Cranney A., Goldsmith C. H., Bensen W. G., Bianchi F., Cividino A., Craig G. L., Kaminska E., Sebaldt R. J., Papaioannou A. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol. 1994 Oct;21(10):1922–1926. [PubMed] [Google Scholar]
  3. Aptekar R. G., Atkinson J. P., Decker J. L., Wolff S. M., Chu E. W. Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease. Arthritis Rheum. 1973 Jul-Aug;16(4):461–467. doi: 10.1002/art.1780160405. [DOI] [PubMed] [Google Scholar]
  4. Ardiles L. G., Valderrama G., Moya P., Mezzano S. A. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Clin Nephrol. 1997 Jan;47(1):1–5. [PubMed] [Google Scholar]
  5. Barrowcliff D. F., Arblaster P. G. Farmer's lung: a study of an early acute fatal case. Thorax. 1968 Sep;23(5):490–500. doi: 10.1136/thx.23.5.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Berger S. P., Seelen M. A., Hiemstra P. S., Gerritsma J. S., Heemskerk E., van der Woude F. J., Daha M. R. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J Am Soc Nephrol. 1996 May;7(5):694–701. doi: 10.1681/ASN.V75694. [DOI] [PubMed] [Google Scholar]
  7. Bradley J. D., Brandt K. D., Katz B. P. Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum. 1989 Jan;32(1):45–53. doi: 10.1002/anr.1780320108. [DOI] [PubMed] [Google Scholar]
  8. Brimnes J., Halberg P., Jacobsen S., Wiik A., Heegaard N. H. Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol. 1997 Nov;110(2):250–256. doi: 10.1111/j.1365-2249.1997.tb08324.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CHURG J., STRAUSS L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951 Mar-Apr;27(2):277–301. [PMC free article] [PubMed] [Google Scholar]
  10. Charles L. A., Caldas M. L., Falk R. J., Terrell R. S., Jennette J. C. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol. 1991 Dec;50(6):539–546. doi: 10.1002/jlb.50.6.539. [DOI] [PubMed] [Google Scholar]
  11. Chumbley L. C., Harrison E. G., Jr, DeRemee R. A. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc. 1977 Aug;52(8):477–484. [PubMed] [Google Scholar]
  12. Churg A., Brallas M., Cronin S. R., Churg J. Formes frustes of Churg-Strauss syndrome. Chest. 1995 Aug;108(2):320–323. doi: 10.1378/chest.108.2.320. [DOI] [PubMed] [Google Scholar]
  13. Cohen P., Guillevin L., Baril L., Lhote F., Noel L. H., Lesavre P. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol. 1995 Mar-Apr;13(2):193–198. [PubMed] [Google Scholar]
  14. Csernok E., Ernst M., Schmitt W., Bainton D. F., Gross W. L. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol. 1994 Feb;95(2):244–250. doi: 10.1111/j.1365-2249.1994.tb06518.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Davies D. J., Moran J. E., Niall J. F., Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):606–606. doi: 10.1136/bmj.285.6342.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Duerr R. H., Targan S. R., Landers C. J., LaRusso N. F., Lindsay K. L., Wiesner R. H., Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991 May;100(5 Pt 1):1385–1391. [PubMed] [Google Scholar]
  17. Eastell R., Reid D. M., Compston J., Cooper C., Fogelman I., Francis R. M., Hosking D. J., Purdie D. W., Ralston S. H., Reeve J. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med. 1998 Oct;244(4):271–292. doi: 10.1046/j.1365-2796.1998.00408.x. [DOI] [PubMed] [Google Scholar]
  18. Fairchild W. V., Spence C. R., Solomon H. D., Gangai M. P. The incidence of bladder cancer after cyclophosphamide therapy. J Urol. 1979 Aug;122(2):163–164. doi: 10.1016/s0022-5347(17)56306-5. [DOI] [PubMed] [Google Scholar]
  19. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  20. Falk R. J., Terrell R. S., Charles L. A., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4115–4119. doi: 10.1073/pnas.87.11.4115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Forde A. M., Feighery C., Jackson J. Anti-monocyte cytoplasmic antibodies in granulomatous disease. Clin Immunol Immunopathol. 1996 Oct;81(1):88–95. doi: 10.1006/clin.1996.0162. [DOI] [PubMed] [Google Scholar]
  22. Frohnert P. P., Sheps S. G. Long-term follow-up study of periarteritis nodosa. Am J Med. 1967 Jul;43(1):8–14. doi: 10.1016/0002-9343(67)90144-1. [DOI] [PubMed] [Google Scholar]
  23. GODMAN G. C., CHURG J. Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol. 1954 Dec;58(6):533–553. [PubMed] [Google Scholar]
  24. Gaffey C. M., Chun B., Harvey J. C., Manz H. J. Phenytoin-induced systemic granulomatous vasculitis. Arch Pathol Lab Med. 1986 Feb;110(2):131–135. [PubMed] [Google Scholar]
  25. Galperin C., Shoenfeld Y., Gilburd B., Esterre P., Meroni P. L., Del Papa N., Halpern G. M., Andriantsimahavandy A., Gershwin M. E. Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. Clin Exp Rheumatol. 1996 Sep-Oct;14(5):479–483. [PubMed] [Google Scholar]
  26. Gaskin G., Clutterbuck E. J., Pusey C. D. Renal disease in the Churg-Strauss syndrome. Diagnosis, management and outcome. Contrib Nephrol. 1991;94:58–65. doi: 10.1159/000420611. [DOI] [PubMed] [Google Scholar]
  27. Golin A. L., Benson R. C., Jr Cyclophosphamide hemorrhagic cystitis requiring urinary diversion. J Urol. 1977 Jul;118(1 Pt 1):110–111. doi: 10.1016/s0022-5347(17)57911-2. [DOI] [PubMed] [Google Scholar]
  28. Golin A. L., Benson R. C., Jr Cyclophosphamide hemorrhagic cystitis requiring urinary diversion. J Urol. 1977 Jul;118(1 Pt 1):110–111. doi: 10.1016/s0022-5347(17)57911-2. [DOI] [PubMed] [Google Scholar]
  29. Green R. L., Vayonis A. G. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet. 1999 Feb 27;353(9154):725–726. doi: 10.1016/S0140-6736(99)00565-6. [DOI] [PubMed] [Google Scholar]
  30. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999 Jan;78(1):26–37. doi: 10.1097/00005792-199901000-00003. [DOI] [PubMed] [Google Scholar]
  31. Guillevin L., Fain O., Lhote F., Jarrousse B., Le Thi Huong D., Bussel A., Leon A. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum. 1992 Feb;35(2):208–215. doi: 10.1002/art.1780350214. [DOI] [PubMed] [Google Scholar]
  32. Guillevin L., Guittard T., Bletry O., Godeau P., Rosenthal P. Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung. 1987;165(3):165–172. doi: 10.1007/BF02714432. [DOI] [PubMed] [Google Scholar]
  33. Guillevin L., Guittard T., Bletry O., Godeau P., Rosenthal P. Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung. 1987;165(3):165–172. doi: 10.1007/BF02714432. [DOI] [PubMed] [Google Scholar]
  34. Guillevin L., Jarrousse B., Lok C., Lhote F., Jais J. P., Le Thi Huong Du D., Bussel A. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol. 1991 Apr;18(4):567–574. [PubMed] [Google Scholar]
  35. Guillevin L., Le Thi Huong D. u., Godeau P., Jais P., Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol. 1988 Aug;27(4):258–264. doi: 10.1093/rheumatology/27.4.258. [DOI] [PubMed] [Google Scholar]
  36. Guillevin L., Lhote F., Cohen P., Jarrousse B., Lortholary O., Généreau T., Léon A., Bussel A. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum. 1995 Nov;38(11):1638–1645. doi: 10.1002/art.1780381116. [DOI] [PubMed] [Google Scholar]
  37. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., Thibult N., Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996 Jan;75(1):17–28. doi: 10.1097/00005792-199601000-00003. [DOI] [PubMed] [Google Scholar]
  38. Guillevin L., Ronco P., Verroust P. Circulating immune complexes in systemic necrotizing vasculitis of the polyarteritis nodosa group. Comparison of HBV-related polyarteritis nodosa and Churg Strauss Angiitis. J Autoimmun. 1990 Dec;3(6):789–792. doi: 10.1016/s0896-8411(05)80044-7. [DOI] [PubMed] [Google Scholar]
  39. Haas C., Geneau C., Odinot J. M., De Jaeger C., Lavner M., Lowenstein W., Choubrac P., Durand H. L'angéite allergique avec granulomatose: syndrome de Churg et Strauss. Etude rétrospective de 16 observations. Ann Med Interne (Paris) 1991;142(5):335–342. [PubMed] [Google Scholar]
  40. Hagen E. C., Daha M. R., Hermans J., Andrassy K., Csernok E., Gaskin G., Lesavre P., Lüdemann J., Rasmussen N., Sinico R. A. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998 Mar;53(3):743–753. doi: 10.1046/j.1523-1755.1998.00807.x. [DOI] [PubMed] [Google Scholar]
  41. Hagen E. C., Daha M. R., Hermans J., Andrassy K., Csernok E., Gaskin G., Lesavre P., Lüdemann J., Rasmussen N., Sinico R. A. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998 Mar;53(3):743–753. doi: 10.1046/j.1523-1755.1998.00807.x. [DOI] [PubMed] [Google Scholar]
  42. Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., Rottem M., Fauci A. S. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992 Mar 15;116(6):488–498. doi: 10.7326/0003-4819-116-6-488. [DOI] [PubMed] [Google Scholar]
  43. Hoffman G. S., Leavitt R. Y., Fleisher T. A., Minor J. R., Fauci A. S. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med. 1990 Oct;89(4):403–410. doi: 10.1016/0002-9343(90)90367-m. [DOI] [PubMed] [Google Scholar]
  44. Hull D. R., McMillan S. A., Rea I. M., Boyd N., McMullin M. F. Antineutrophil cytoplasmic antibodies in myelodysplasia. Ulster Med J. 1996 May;65(1):55–57. [PMC free article] [PubMed] [Google Scholar]
  45. Imai H., Nakamoto Y., Hirokawa M., Akihama T., Miura A. B. Carbamazepine-induced granulomatous necrotizing angiitis with acute renal failure. Nephron. 1989;51(3):405–408. doi: 10.1159/000185332. [DOI] [PubMed] [Google Scholar]
  46. Jarzobski J., Ferry J., Wombolt D., Fitch D. M., Egan J. D. Vasculitis with allopurinol therapy. Am Heart J. 1970 Jan;79(1):116–121. doi: 10.1016/0002-8703(70)90401-1. [DOI] [PubMed] [Google Scholar]
  47. Jayne D. R., Davies M. J., Fox C. J., Black C. M., Lockwood C. M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet. 1991 May 11;337(8750):1137–1139. doi: 10.1016/0140-6736(91)92797-6. [DOI] [PubMed] [Google Scholar]
  48. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  49. Johnson W. W., Meadows D. C. Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. N Engl J Med. 1971 Feb 11;284(6):290–294. doi: 10.1056/NEJM197102112840602. [DOI] [PubMed] [Google Scholar]
  50. Jones R. E., Chatham W. W. Update on sarcoidosis. Curr Opin Rheumatol. 1999 Jan;11(1):83–87. doi: 10.1097/00002281-199901000-00015. [DOI] [PubMed] [Google Scholar]
  51. Katz R. S., Papernik M. Zafirlukast and Churg-Strauss syndrome. JAMA. 1998 Jun 24;279(24):1949–1950. [PubMed] [Google Scholar]
  52. Kerr G. S., Fleisher T. A., Hallahan C. W., Leavitt R. Y., Fauci A. S., Hoffman G. S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum. 1993 Mar;36(3):365–371. doi: 10.1002/art.1780360312. [DOI] [PubMed] [Google Scholar]
  53. Kinoshita M., Shiraishi T., Koga T., Ayabe M., Rikimaru T., Oizumi K. Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):534–535. doi: 10.1016/s0091-6749(99)70483-5. [DOI] [PubMed] [Google Scholar]
  54. Knoell D. L., Lucas J., Allen J. N. Churg-Strauss syndrome associated with zafirlukast. Chest. 1998 Jul;114(1):332–334. doi: 10.1378/chest.114.1.332. [DOI] [PubMed] [Google Scholar]
  55. Lanham J. G., Elkon K. B., Pusey C. D., Hughes G. R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984 Mar;63(2):65–81. doi: 10.1097/00005792-198403000-00001. [DOI] [PubMed] [Google Scholar]
  56. Little P., Gould C., Williamson I., Warner G., Gantley M., Kinmonth A. L. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ. 1997 Aug 9;315(7104):350–352. doi: 10.1136/bmj.315.7104.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Lockwood C. M., Thiru S., Isaacs J. D., Hale G., Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet. 1993 Jun 26;341(8861):1620–1622. doi: 10.1016/0140-6736(93)90759-a. [DOI] [PubMed] [Google Scholar]
  58. Martin S. J., Audrain M. A., Oksman F., Ecoiffier M., Attal M., Milpied N., Esnault V. L. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997 Jul;20(1):45–48. doi: 10.1038/sj.bmt.1700828. [DOI] [PubMed] [Google Scholar]
  59. Masi A. T., Hunder G. G., Lie J. T., Michel B. A., Bloch D. A., Arend W. P., Calabrese L. H., Edworthy S. M., Fauci A. S., Leavitt R. Y. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990 Aug;33(8):1094–1100. doi: 10.1002/art.1780330806. [DOI] [PubMed] [Google Scholar]
  60. Mathieson P. W., Cobbold S. P., Hale G., Clark M. R., Oliveira D. B., Lockwood C. M., Waldmann H. Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med. 1990 Jul 26;323(4):250–254. doi: 10.1056/NEJM199007263230407. [DOI] [PubMed] [Google Scholar]
  61. Matthay R. A., Schwarz M. I., Petty T. L., Stanford R. E., Gupta R. C., Sahn S. A., Steigerwald J. C. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975 Sep;54(5):397–409. doi: 10.1097/00005792-197509000-00003. [DOI] [PubMed] [Google Scholar]
  62. Medina F., Camargo A., Moreno J., Zonana-Nacach A., Aceves-Avila J., Fraga A. Anti-neutrophil cytoplasmic autoantibodies in leprosy. Br J Rheumatol. 1998 Mar;37(3):270–273. doi: 10.1093/rheumatology/37.3.270. [DOI] [PubMed] [Google Scholar]
  63. Mulder H., Struys A. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol. 1994 Apr;33(4):348–350. doi: 10.1093/rheumatology/33.4.348. [DOI] [PubMed] [Google Scholar]
  64. Mulder L., van Rossum M., Horst G., Limburg P., de Graeff-Meeder E. R., Kuis W., Kallenberg C. Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis. J Rheumatol. 1997 Mar;24(3):568–575. [PubMed] [Google Scholar]
  65. Murakami M., Kawabe K., Hosoi Y., Hojo S., Dobashi K., Iriuchijima T., Nakazawa T., Mori M. Decreased pulmonary perfusion in hypersensitivity pneumonitis caused by Shiitake mushroom spores. J Intern Med. 1997 Jan;241(1):85–88. doi: 10.1046/j.1365-2796.1997.83103000.x. [DOI] [PubMed] [Google Scholar]
  66. Nishiya K., Chikazawa H., Nishimura S., Hisakawa N., Hashimoto K. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol. 1997 Jan;16(1):70–75. doi: 10.1007/BF02238766. [DOI] [PubMed] [Google Scholar]
  67. Nowack R., Birck R., van der Woude F. J. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet. 1997 Mar 15;349(9054):774–774. doi: 10.1016/S0140-6736(05)60198-5. [DOI] [PubMed] [Google Scholar]
  68. Park K. E., Chipps D. R., Benson E. M. Necrotizing vasculitis secondary to propylthiouracil presenting as purpura fulminans. Rheumatology (Oxford) 1999 Aug;38(8):790–792. doi: 10.1093/rheumatology/38.8.790. [DOI] [PubMed] [Google Scholar]
  69. Plotz P. H., Klippel J. H., Decker J. L., Grauman D., Wolff B., Brown B. C., Rutt G. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Ann Intern Med. 1979 Aug;91(2):221–223. doi: 10.7326/0003-4819-91-2-221. [DOI] [PubMed] [Google Scholar]
  70. Pudifin D. J., Duursma J., Gathiram V., Jackson T. F. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Clin Exp Immunol. 1994 Jul;97(1):48–51. doi: 10.1111/j.1365-2249.1994.tb06578.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Pusey C. D., Rees A. J., Evans D. J., Peters D. K., Lockwood C. M. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int. 1991 Oct;40(4):757–763. doi: 10.1038/ki.1991.272. [DOI] [PubMed] [Google Scholar]
  72. Reinhold-Keller E., Kekow J., Schnabel A., Schmitt W. H., Heller M., Beigel A., Duncker G., Gross W. L. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum. 1994 Jun;37(6):919–924. doi: 10.1002/art.1780370622. [DOI] [PubMed] [Google Scholar]
  73. Rosenwasser L. J. Leukotriene modifiers: new drugs, old and new reactions. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):374–375. doi: 10.1016/s0091-6749(99)70459-8. [DOI] [PubMed] [Google Scholar]
  74. Savage C. O., Gaskin G., Pusey C. D., Pearson J. D. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens. Exp Nephrol. 1993 May-Jun;1(3):190–195. [PubMed] [Google Scholar]
  75. Savige J. A., Chang L., Horn S., Crowe S. M. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity. 1994;18(3):205–211. doi: 10.3109/08916939409007997. [DOI] [PubMed] [Google Scholar]
  76. Schnabel A., Hauschild S., Gross W. L. Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int Arch Allergy Immunol. 1996 Mar;109(3):201–206. doi: 10.1159/000237238. [DOI] [PubMed] [Google Scholar]
  77. Schwarz M. I., Sutarik J. M., Nick J. A., Leff J. A., Emlen J. W., Tuder R. M. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med. 1995 Jun;151(6):2037–2040. doi: 10.1164/ajrccm.151.6.7767555. [DOI] [PubMed] [Google Scholar]
  78. Seal R. M., Hapke E. J., Thomas G. O., Meek J. C., Hayes M. The pathology of the acute and chronic stages of farmer's lung. Thorax. 1968 Sep;23(5):469–489. doi: 10.1136/thx.23.5.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Snook J. A., Chapman R. W., Fleming K., Jewell D. P. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 1989 Apr;76(1):30–33. [PMC free article] [PubMed] [Google Scholar]
  80. Stillwell T. J., Benson R. C., Jr, DeRemee R. A., McDonald T. J., Weiland L. H. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum. 1988 Apr;31(4):465–470. doi: 10.1002/art.1780310402. [DOI] [PubMed] [Google Scholar]
  81. Tervaert J. W., Huitema M. G., Hené R. J., Sluiter W. J., The T. H., van der Hem G. K., Kallenberg C. G. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990 Sep 22;336(8717):709–711. doi: 10.1016/0140-6736(90)92205-v. [DOI] [PubMed] [Google Scholar]
  82. Venning M. C., Quinn A., Broomhead V., Bird A. G. Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med. 1990 Dec;77(284):1287–1296. doi: 10.1093/qjmed/77.3.1287. [DOI] [PubMed] [Google Scholar]
  83. Wechsler M. E., Garpestad E., Flier S. R., Kocher O., Weiland D. A., Polito A. J., Klinek M. M., Bigby T. D., Wong G. A., Helmers R. A. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA. 1998 Feb 11;279(6):455–457. doi: 10.1001/jama.279.6.455. [DOI] [PubMed] [Google Scholar]
  84. Worthy S. A., Müller N. L., Hansell D. M., Flower C. D. Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. AJR Am J Roentgenol. 1998 Feb;170(2):297–300. doi: 10.2214/ajr.170.2.9456932. [DOI] [PubMed] [Google Scholar]
  85. Yahya T. M., Benedict S., Shalabi A., Bayoumi R. Anti-neutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G. Clin Exp Immunol. 1997 Oct;110(1):41–44. doi: 10.1046/j.1365-2249.1997.4981395.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Zhao M. H., Jayne D. R., Ardiles L. G., Culley F., Hodson M. E., Lockwood C. M. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM. 1996 Apr;89(4):259–265. doi: 10.1093/qjmed/89.4.259. [DOI] [PubMed] [Google Scholar]
  87. de Bandt M., Ollivier V., Meyer O., Babin-Chevaye C., Khechaï F., de Prost D., Hakim J., Pasquier C. Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells. Arthritis Rheum. 1997 Nov;40(11):2030–2038. doi: 10.1002/art.1780401116. [DOI] [PubMed] [Google Scholar]
  88. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES